Feasibility of therapeutic plasma exchange-based combination therapy in the treatment of acquired hemophilia A: A retrospective 6 case series

Poor availability and a lack of affordability of bypassing agents (recombinant activated factor VII and activated prothrombin complex concentrate) in west China prompted us to investigate an alternative cost-effective combination therapy. We aimed to explore the feasibility of therapeutic plasma exc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lin-Yue, Shen, Yan, Zeng, Han-Qing, Zhang, Ying, Lou, Shi-Feng, Deng, Jian-Chuan, Luo, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294921/
https://www.ncbi.nlm.nih.gov/pubmed/34398013
http://dx.doi.org/10.1097/MD.0000000000026587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294921/
https://www.ncbi.nlm.nih.gov/pubmed/34398013
http://dx.doi.org/10.1097/MD.0000000000026587

Ejemplares similares